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Clostridium difficile, belonging to ribotype 018 (RT018), is one of the most prevalent genotypes circulating in hospital settings in
Italy. Here, we report the draft genome of C. difficile CD8-15 belonging to RT018, isolated from a patient with fatal C. difficile-
associated infection.
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Clostridium difficile infection (CDI) is one of the most commonhospital-acquired infections and the leading cause of
antibiotic-associated diarrhea and pseudomembranous colitis
(1). Increasing CDI incidence rates have been mainly attributed to
successful clones belonging to a few predominant ribotypes (RTs),
with different distribution in different geographic regions (2, 3).
RT018 has been reported as one of the most prevalent geno-
types circulating in hospital settings in Italy (4, 5) and in the Far
East (i.e., South Korea and Japan) (6, 7) but has been rarely de-
scribed in other countries (2, 8). RT018 is highly transmissible and
generally shows a multidrug-resistant phenotype. It produces
both toxin A and toxin B, but is negative for binary toxin, and is
associated with complicated outcomes (4, 7, 9). In this report, we
announce the draft genome of C. difficile CD8-15 belonging to
RT018, which was isolated from a patient admitted to a hospital in
Florence (central Italy) in 2015 with fatal C. difficile-associated
infection evolved as toxic megacolon.
C. difficile CD8-15 was grown in 5 ml of thioglicollate broth
and incubated under anaerobic conditions for 48 h at 37°C.
Genomic DNA was subjected to whole-genome sequencing with
the MiSeq platform (Illumina Inc., San Diego, CA, USA) using a
2300-bp paired-end approach. A total of 2,118,990 reads were
generated and then de novo assembled using SPAdes version 3.6.1
(10) into 44 scaffolds (largest scaffold  831,956 bp; N50 
235,991 bp; L50  5; average GC  28.63%), with an estimated
genome size of 4,249,791 bp and an average coverage of 50.
The draft genome was then subjected to the following in silico
analyses: (i) multilocus sequence typing (MLST; http://pubmlst
.org/cdifficile); (ii) toxinotyping (http://www.mf.uni-mb.si
/mikro/tox); (iii) detection of antibiotic resistance mechanisms,
using the C. difficile 630 strain (11). The presence of phage-related
sequences and CRISPR-Cas systems were investigated using
PHAST (http://phast.wishartlab.com) and CRISPRFinder (http:
//crispr.u-psud.fr), respectively.
MLST analysis assigned C. difficile CD8-15 to sequence type
(ST) 17, as previously reported for other C. difficile strains belong-
ing to RT018 (12, 13). ST17 and other STs of C. difficile belong to
clade I (12). Toxinotyping classified C. difficile CD8-15 as a non-
variant strain (toxinotype 0) producing toxin A and toxin B but
not binary toxin CDT.
C. difficile CD8-15 was resistant to rifampin (MIC32 mg/L),
levofloxacin (MIC 32 mg/L), and erythromycin (MIC 256
mg/L) but remained susceptible to clindamycin (MIC 2 mg/L).
Sequence analysis revealed the presence of point mutations in the
rpoB gene (R505K and I548M), which is known to be associated
with high-level resistance to rifamycins (14). Mutations were de-
tected also in the quinolone resistance-determining region of gyrA
(T82I), which is consistent with the fluoroquinolones resistance
phenotype. Resistance to erythromycin was likely attributable to
the presence of a multidrug efflux system encoded by the cme gene
(15), while erm genes and other genes involved in macrolides re-
sistance (i.e., mef, msr, cfr) were not detected (9, 16). PHAST iden-
tified 3 intact and 5 incomplete prophage regions. CRISPRFinder
identified two class I CRISPR-Cas systems.
Accession number(s). This whole-genome shotgun project
has been deposited at DDBJ/EMBL/GenBank under the accession
number LYDP00000000.
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